פרופ' תמנע נפתלי
מומחית לרפואה פנימית וגסטרואנטרולוגיה
Specialist in Internal Medicine and Gastroenterology
Deputy Director, IBD service director
The Institute of Gastroenterology and Hepatology
Sapir Medical center, Meir hospital, Israel
סגנית מנהל המכון לגסטרואנטרולוגיה ומחלות הכבד,
מנהלת השירות למחלות מעי דלקתיות,
בי"ח מאיר כפר סבא
Senior Lecturer
Sackler school of Medicine, Tel Aviv University, Israel
מרצה בכירה, בית הספר לרפואה ע"ש סאקלר,
אוניברסיטת תל אביב
Selected Publications
During the years, Prof. Naftali conducted research in the field of functional bowel diseases, including esophageal motility problems, gastroparesis, chronic constipation, fecal incontinence and more. In the field of IBD Prof. Naftali published studies involving, among other topics, treatment with cyclosporine in sever ulcerative colitis, adherence of patients to medical treatment, and more.
Furthermore, Prof. Naftali published several pioneering studies regarding cannabis treatment in sever IBD. These studies have shown that although cannabis does not improve the inflammation, it can induce symptomatic relief. In order to further understand the effect of cannabis on IBD, Prof. Naftali established the Gastro Cannabis laboratory in which the exploration of the effect of cannabinoids on the gastrointestinal tract continues.